Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Leiomyoma × relugolix × Clear all

Status

Recruiting 4 Completed 4 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 7 Pregnancy Complications 1 Leiomyoma 1 Endometriosis 1 Adenocarcinoma 1

Interventions

ulipristal acetate 1 relugolix 1 Uterine Myomectomy 1 Triamcinolone Acetonide 1 Triamcinolone 1 Tablets 1 Surgical Procedures, Operative 1 Norethindrone Acetate 1 Laparoscopy 1 Iohexol 1 Estradiol 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05739136 2025-08-01

MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

Sumitomo Pharma Switzerland GmbH

Active not recruiting

Endometriosis, Leiomyoma, Pregnancy Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡